119 related articles for article (PubMed ID: 1966596)
61. Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S
Immunotherapy; 2018 Apr; 10(5):411-421. PubMed ID: 29473472
[TBL] [Abstract][Full Text] [Related]
62. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W
Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
[TBL] [Abstract][Full Text] [Related]
63. Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
Li B; Wang Y; Chen J; Wu H; Chen W
Clin Exp Immunol; 2005 May; 140(2):310-9. PubMed ID: 15807856
[TBL] [Abstract][Full Text] [Related]
64. Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.
Koyama K; Akiyama K; Kawahara H; Egashira A; Murakami H
Jpn J Cancer Res; 1990 Oct; 81(10):967-70. PubMed ID: 2121682
[TBL] [Abstract][Full Text] [Related]
65. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
[TBL] [Abstract][Full Text] [Related]
66. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
67. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
68. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.
Han Y; Wu Y; Yang C; Huang J; Guo Y; Liu L; Chen P; Wu D; Liu J; Li J; Zhou X; Hou J
J Transl Med; 2017 Mar; 15(1):64. PubMed ID: 28330473
[TBL] [Abstract][Full Text] [Related]
69. [Prepared the monoclonal antibody associated with hepatocellular carcinoma and analyzed its epitope].
Yang BF; Liu R; Liu Y; Yang JJ; Liu XL; Gao JE; Sun QH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):780-3. PubMed ID: 21722534
[TBL] [Abstract][Full Text] [Related]
70. The activity of γδ T cells against paediatric liver tumour cells and spheroids in cell culture.
Hoh A; Dewerth A; Vogt F; Wenz J; Baeuerle PA; Warmann SW; Fuchs J; Armeanu-Ebinger S
Liver Int; 2013 Jan; 33(1):127-36. PubMed ID: 23088518
[TBL] [Abstract][Full Text] [Related]
71. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
Glassy MC; Handley HH; Hagiwara H; Royston I
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6327-31. PubMed ID: 6604917
[TBL] [Abstract][Full Text] [Related]
72. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody-based gene delivery system.
Mohr L; Schauer JI; Boutin RH; Moradpour D; Wands JR
Hepatology; 1999 Jan; 29(1):82-9. PubMed ID: 9862854
[TBL] [Abstract][Full Text] [Related]
73. Preparation and characterization of a new monoclonal antibody against CXCR4 using lentivirus vector.
Li X; Kuang Y; Huang X; Zou L; Huang L; Yang T; Li W; Yang Y
Int Immunopharmacol; 2016 Jul; 36():100-105. PubMed ID: 27124560
[TBL] [Abstract][Full Text] [Related]
74. Definition of tumor-associated antigens in hepatocellular carcinoma.
Stenner-Liewen F; Luo G; Sahin U; Tureci O; Koslovski M; Kautz I; Liewen H; Pfreundschuh M
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):285-90. PubMed ID: 10750667
[TBL] [Abstract][Full Text] [Related]
75. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
[TBL] [Abstract][Full Text] [Related]
76. Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells.
Masumoto A; Arao S; Otsuki M
Hepatology; 1999 Jan; 29(1):68-74. PubMed ID: 9862852
[TBL] [Abstract][Full Text] [Related]
77. A monoclonal antibody to the carbohydrate chain on human hepatocellular carcinoma-associated antigen which suppressed tumor growth in nude mice.
Fukuda Y; Imai K; Miura K; Matsui M; Nakanishi T; Nakazato H; Masukawa J; Higashide T; Hinoda Y; Noguchi T
Cancer Immunol Immunother; 1988; 27(1):26-32. PubMed ID: 2840199
[TBL] [Abstract][Full Text] [Related]
78. Definition of human melanoma-associated cell surface antigens by hybridoma monoclonal antibodies.
Burk MW; Saxton RE; Mann BD; Morton DL
Surgery; 1983 Jul; 94(1):84-90. PubMed ID: 6857516
[TBL] [Abstract][Full Text] [Related]
79. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
80. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
